Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2023

May 15, 2023

SELL
$18.67 - $24.56 $37,340 - $49,120
-2,000 Closed
0 $0
Q3 2022

May 15, 2023

BUY
$9.4 - $18.59 $18,800 - $37,180
2,000 New
2,000 $35,000
Q2 2022

Aug 15, 2022

SELL
$9.12 - $18.9 $508,895 - $1.05 Million
-55,800 Reduced 96.54%
2,000 $19,000
Q3 2021

Nov 15, 2021

BUY
$7.07 - $17.5 $408,646 - $1.01 Million
57,800 New
57,800 $939,000

Others Institutions Holding ISEE

About IVERIC bio, Inc.


  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.